TARO-IMIQUIMOD DIN 02482975
Health Canada record
| Active ingredient(s) | IMIQUIMOD 5 % |
|---|---|
| Dosage form | Cream |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D06BB10 IMIQUIMOD |
| Original market date | |
| Current status date | 22-Nov-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing IMIQUIMOD
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02239505 | ALDARA P | BAUSCH HEALTH, CANADA INC. | Cream | IMIQUIMOD 5 % | Marketed |
| 02413582 | IMIQUIMOD | BAUSCH HEALTH, CANADA INC. | Cream | IMIQUIMOD 5 % | Approved |
| 02482983 | TARO-IMIQUIMOD PUMP | TARO PHARMACEUTICALS INC | Cream | IMIQUIMOD 5 % | Marketed |
| 02365561 | VYLOMA | BAUSCH HEALTH, CANADA INC. | Cream | IMIQUIMOD 3.75 % | Marketed |
| 02340445 | ZYCLARA | BAUSCH HEALTH, CANADA INC. | Cream | IMIQUIMOD 3.75 % | Marketed |
| 02392054 | ZYCLARA | BAUSCH HEALTH, CANADA INC. | Cream | IMIQUIMOD 2.5 % | Approved |
| 02407825 | APO-IMIQUIMOD | APOTEX INC | Cream | IMIQUIMOD 5 % | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21553 | 2018-11-22 | Abbreviated New Drug Submission (ANDS) |
International API supply for IMIQUIMOD
11 active FDA Drug Master Files.
Request a quote for TARO-IMIQUIMOD